Urological Manifestations
10
3
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Brain Activity Among Children With Overactive Bladder and Daytime Urinary Incontinence and Healthy Children
The Voided Urinary, Perineal, and Faecal Microbiota Among Children and Adolescents - the PpUF-study.
INTIBIA Pivotal Study
A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder
Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies
Optic Nerve Sheath Diameter in Urologic Surgery
Autologous Cell Therapy for Stress Urinary Incontinence in Males Following Prostate Surgery
Actual Use Study of Tamsulosin in Men
Prostatic Artery Embolization for Benign Prostatic Obstruction
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate Cancer